Dose-escalation Study of Oral Administration of S 055746 in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome

NCT02920541 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukaemia (AML)
Myelodysplastic Syndrome (MDS)

Interventions

DRUG: S 055746

Sponsor

Institut de Recherches Internationales Servier

Collaborators

[object Object]